Duloxetine: a new treatment for the emotional and physical symptoms of depression

CH Mallinckrodt, DJ Goldstein, MJ Detke… - … care companion to …, 2003 - psychiatrist.com
Background: Depression is underdiagnosed in the primary care setting. Physical symptoms
such as aches, pains, and gastrointestinal disturbance are frequently associated with major …

[HTML][HTML] Efficacy and safety of duloxetine 60 mg once daily in major depressive disorder: a review with expert commentary

SG Ball, D Desaiah, Q Zhang, ME Thase… - Drugs in …, 2013 - ncbi.nlm.nih.gov
Objective: Major depressive disorder (MDD) is a significant public health concern and
challenges health care providers to intervene with appropriate treatment. This article …

Efficacy and safety of duloxetine in patients with chronic low back pain

V Skljarevski, D Desaiah, H Liu-Seifert, Q Zhang… - 2010 - journals.lww.com
Study Design. This was a randomized, double-blind, placebo-controlled clinical trial.
Objective. To assess the efficacy and safety of duloxetine in the treatment of chronic low …

Duloxetine in the treatment of depression: a double-blind placebo-controlled comparison with paroxetine

DJ Goldstein, Y Lu, MJ Detke, C Wiltse… - Journal of clinical …, 2004 - journals.lww.com
Objective: To evaluate duloxetine, a dual reuptake inhibitor of serotonin and norepinephrine,
on improvement of emotional and painful physical symptoms. Design: Randomized, double …

Effects of duloxetine on painful physical symptoms associated with depression

DJ Goldstein, Y Lu, MJ Detke, J Hudson, S Iyengar… - Psychosomatics, 2004 - Elsevier
Painful physical symptoms are common features of major depressive disorder and may be
the presenting complaints in primary care settings. The effect of the dual serotonin (5-HT) …

Comparative efficacy of amitriptyline, duloxetine and pregabalin for treating fibromyalgia in adults: an overview with network meta-analysis

FF Alberti, MW Becker, CR Blatt, PK Ziegelmann… - Clinical …, 2022 - Springer
Abstract Treatment recommendations for fibromyalgia (FM) include a range of predominantly
pharmacological treatment options designed to ensure the maintenance of symptoms and …

Pharmacological treatments of fibromyalgia in adults; overview of phase IV clinical trials

NM Alorfi - Frontiers in Pharmacology, 2022 - frontiersin.org
Background: Fibromyalgia is a chronic neurological condition characterized by widespread
pain. The effectiveness of current pharmacological treatments is limited. However, several …

Long-term trials of pregabalin and duloxetine for fibromyalgia symptoms: how study designs can affect placebo factors

R Staud, DD Price - Pain, 2008 - journals.lww.com
The results of two 6-month long, randomized, double-blind, controlled trials (RCT) of the
anticonvulsant pregabalin [5] and the balanced serotonin–norepinephrine re-uptake …

A double‐blind, randomized, placebo‐controlled study of the efficacy and safety of duloxetine for the treatment of chronic pain due to osteoarthritis of the knee

AS Chappell, D Desaiah, H Liu‐Seifert, S Zhang… - Pain …, 2011 - Wiley Online Library
Objective: To evaluate the efficacy and safety of duloxetine in the treatment of chronic pain
due to osteoarthritis of the knee. Methods: This was a 13‐week, randomized, double‐blind …

Evaluation of patient-rated stiffness associated with fibromyalgia: a post-hoc analysis of 4 pooled, randomized clinical trials of duloxetine

R Bennett, IJ Russell, E Choy, M Spaeth, P Mease… - Clinical …, 2012 - Elsevier
BACKGROUND: Patients with fibromyalgia (FM) rate stiffness as one of the most
troublesome symptoms of the disorder. However, there are few published studies that have …